| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 07/22/2004 | WO2004060899A1 Phospholipid derivatives and process for the production there |
| 07/22/2004 | WO2004060890A1 2-oxopyridin-3-yl thia (di) azole derivates for use in the treatment of cell proliferation and apoptosis related diseases |
| 07/22/2004 | WO2004060881A1 1,3-benzothiazinone derivatives, process for producing the same and use thereof |
| 07/22/2004 | WO2004060488A1 17 beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases |
| 07/22/2004 | WO2004060398A1 Connexin 26 inhibitors and cancer metastasis inhibitors |
| 07/22/2004 | WO2004060390A2 Use of a specific inhibitor of the 5ht2b receptor for the treatment of cancer |
| 07/22/2004 | WO2004060376A1 The r-isomer of beta amino acid compounds as integrin receptor antagonists derivatives |
| 07/22/2004 | WO2004060304A2 Novel compositions and methods in cancer |
| 07/22/2004 | WO2004060270A2 Compositions and methods for the diagnosis and treatment of tumor |
| 07/22/2004 | WO2004060264A2 Metastin derivatives and their use |
| 07/22/2004 | WO2004060262A2 Modulators of notch signalling for use in immunotherpapy |
| 07/22/2004 | WO2004060261A2 Novel factor viia inhibiting compounds |
| 07/22/2004 | WO2004060055A1 Wt1 transgenic animal |
| 07/22/2004 | WO2004039359A3 Use of pyrimidine derivates for the manifacture of a medicament for the treatment of hyper-proliferative disorders |
| 07/22/2004 | WO2004037235A3 Method and composition for preventing and treating solid tumors |
| 07/22/2004 | WO2004037187A8 Metal-containing materials, compositions and methods |
| 07/22/2004 | WO2004035034A3 Clofarabine and taxane chemotherapy combination |
| 07/22/2004 | WO2004035033A3 Clofarabine and camptothecin chemotherapy combination |
| 07/22/2004 | WO2004024884A3 Syts as modifiers of the p21 pathway and methods of use |
| 07/22/2004 | WO2004024735A3 A new process for the preparation of epothilone derivatives, new epothilone derivatives as well as new intermediate products for the process and the methods of preparing same |
| 07/22/2004 | WO2004024086A3 Compounds, compositions and methods |
| 07/22/2004 | WO2004021977A3 Nucleic acid and corresponding protein entitled 98p4b6 useful in treatment and detection of cancer |
| 07/22/2004 | WO2004006835A3 Novel compounds, pharmaceutical compositions containing same, and methods of use for same |
| 07/22/2004 | WO2004005529A3 GEF-H1b: BIOMARKERS, COMPLEXES, ASSAYS AND THERAPEUTIC USES THEREOF |
| 07/22/2004 | WO2003103743A3 Medical device for intra-lumenal delivery of pharmaceutical agents |
| 07/22/2004 | WO2003103583A8 A method for using tethered bis(polyhydroxyphenyls) and o-alkyl derivatives thereof in treating inflammatory conditions of the central nervous system |
| 07/22/2004 | WO2003101919A3 Scorpionate-like pendant macrocyclic ligands, complexes and compositions thereof, and methods of using same |
| 07/22/2004 | WO2003087304A3 Tri-substituted heteroaryls and methods of making and using the same |
| 07/22/2004 | WO2003070675A3 Substituted 10-aryl-11h-benzo[b]fluorenes and 7-aryl-5,6-dihydro-benzo[a]anthracenes for selective effects on estrogen receptors |
| 07/22/2004 | WO2003059293A3 17-hydroxy-4-aza-androstan-3-ones as androgen receptor modulators |
| 07/22/2004 | WO2003059148A3 Gene expression profiles in stomach cancer |
| 07/22/2004 | WO2003053215A3 Diagnosis prognosis and identification of potential therapeutic targets of multiple myeloma based on gene expression profiling |
| 07/22/2004 | WO2003014299A3 SPHKs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE |
| 07/22/2004 | WO2003014296A3 A group of novel anti-cancer compounds with specific structure |
| 07/22/2004 | WO2003006002A9 Compositions and methods of administering tubulin binding agents for the treatment of ocular diseases |
| 07/22/2004 | WO2002101076A3 Methods for targeted expression of therapeutic nucleic acid |
| 07/22/2004 | WO2002099048A3 LIMKs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE |
| 07/22/2004 | WO2002088090A3 Pyrazole derived kinase inhibitors |
| 07/22/2004 | US20040143131 in particular,manufacturing a 5-(tert-butylcarbamoyl)-aminomethyl-oxazolidinone by condensing a carbamate with a tert-butylcarbamoyl protected derivative of glycidylamine or 3-amino-1-halopropanol, intermediates |
| 07/22/2004 | US20040143117 serine/threonine kinase inhibitors; 2,3-diphenylquinoxalines in which at least one of the phenyls is substituted with an amine group, particularly 2-[4-(2-aminoprop-2-yl)phenyl]-3-phenylquinoxaline; treating cancer |
| 07/22/2004 | US20040143115 e.g., 1-[2-Benzoxazol-2-ylaminomethyl)-piperidin-1-yl]-1-(2-methyl-5phenyl-thiazol4-yl)-methanone; used to treat disorders where an antagonist of a human orexin receptor is required |
| 07/22/2004 | US20040143101 Immunoglobulin construct containing anti-mucin variable domain sequences for eliciting an anti-idiotype anti-tumor response |
| 07/22/2004 | US20040143014 Therapeutic use of alpha-2-delta ligands |
| 07/22/2004 | US20040142999 Novel compounds and compositions as cathepsin inhibitors |
| 07/22/2004 | US20040142990 Concentrating epothilone in culture; complexing; antiproliferative agents |
| 07/22/2004 | US20040142987 3-aminoalkyl-2-aryl-indole derivatives and their use as gnrh antagonists |
| 07/22/2004 | US20040142982 Urea derivatives as integrin alpha 4 antagonists |
| 07/22/2004 | US20040142979 Cardiovascular disorders; respiratory system disorders; kidneys; liver diosrders; central nervous system diosrders; osteoarthritis; antiarthritic agents; antitumor agents; multiple sclerosis |
| 07/22/2004 | US20040142976 Modulation cytokine sensitive diseases, cellular adhesion molecules; Aids therapy; antihistamines; antiarthritic agents; bone disorders; malaria; cachexia; Crohn's disease |
| 07/22/2004 | US20040142963 Cardiovascular disorders |
| 07/22/2004 | US20040142960 Yohimbine as immunobiologically active agent |
| 07/22/2004 | US20040142953 Inhibitors of histone deacetylase |
| 07/22/2004 | US20040142952 Triazoloquinazoline and pyrazolotriazolopyrimidine derivatives, medicinal compositions, adenosine a3 receptor affinity agents, ocular tension lowering agents, preparations for preventing and treating glaucoma and method of lowering ocular tension |
| 07/22/2004 | US20040142947 Pyrrolopyrimidines |
| 07/22/2004 | US20040142934 treatment of rheumatoid arthritis and/or pain; INHIBIT activity of VEGF receptor tyrosine kinase and VEGF-dependent cell proliferation |
| 07/22/2004 | US20040142932 treating diseases and conditions caused or exacerbated by unregulated p38 MAP Kinase activity |
| 07/22/2004 | US20040142927 Inhibitors of p38 |
| 07/22/2004 | US20040142920 acute or chronic transplant rejection or inflammatory or autoimmune diseases |
| 07/22/2004 | US20040142919 Benzazepinone alpha vintegrin receptor antagonists |
| 07/22/2004 | US20040142909 Colchinol derivatives as angiogenesis inhibitors |
| 07/22/2004 | US20040142900 polypeptide with the transport function of herpesviral VP22 protein and which can regulate cell cycle progression, e.g. proteins which can induce apoptosis, or proteins which can arrest cells from the cell cycle to arrest cell proliferation |
| 07/22/2004 | US20040142885 host cell; gene therapy |
| 07/22/2004 | US20040142882 Use of glycyrrhizin and its derivatives as RANTES inducers |
| 07/22/2004 | US20040142877 Ligands of the $g(a)v$g(b)6 integrin |
| 07/22/2004 | US20040142875 "metastin" is the ligand to a G-protein-coupled orphan receptor known as OT7T175 or AXOR12; prodrug; treating cancer, hydatid mole, invasive mole, miscarriage, fetal hypoplasia, sugar dysbolism, lipid dysbolism or labor induction in a mammal |
| 07/22/2004 | US20040142867 Stabilized proteinic preparation |
| 07/22/2004 | US20040142851 by inducing the apoptosis according to a inhibition mechanism of the enzyme activities of proteasome |
| 07/22/2004 | US20040142432 Preparing single chain antibodies comprised of camelid subunits for treating and preventing inflammation, allergies, cancer, infections, transplant rejection, autoimmune and muscular disorders |
| 07/22/2004 | US20040142431 Nucleotide sequences comprising restriction fragment length polymorphisms coding polypeptide with antiproliferative, antiviral and antiparasitic effects |
| 07/22/2004 | US20040142404 Designing cyclic peptide which modulates tyrosine kinase activity and can be used as potential treatment for asthma, eczema, food allergies, cancer, inflammatory bowel and autoimmune diseases; enzyme inhibitors |
| 07/22/2004 | US20040142395 Compositions and methods for identifying agents which modulate PTEN function and PI-3 kinase pathways |
| 07/22/2004 | US20040142394 Method for diagnosing a tumor in a patient determining the concentration of PIBF |
| 07/22/2004 | US20040142354 used to diagnose and/or treat a wide variety of liver and other disorders (cancer) and tracing hepatocyte lineage; genetic engineering |
| 07/22/2004 | US20040142349 kit for detecting a risk of cancer, coronary or cerebrovascular disease, hypertension, type 2 diabetes, dementia, joint arthrosis, cataract, or sensitivity to organophosphorus compounds |
| 07/22/2004 | US20040142342 Antibodies to non-functional P2X7 receptor diagnosis and treatment of cancers and other conditions |
| 07/22/2004 | US20040142317 Use of amino acid transporter atbo,+ as a delivery system for drugs and prodrugs |
| 07/22/2004 | US20040142047 Korean acanthopanax senticosus extract, protein extract, crude protein-polysaccharide which were extracted from korean acanthopanax senticosus, and immunoregulating compositions comprising the same and use thereof |
| 07/22/2004 | US20040142000 Immune activator |
| 07/22/2004 | US20040141992 derived from the same antigen as the substance eliciting the allergic reaction; contains an epitope different from that evoking the allergic reaction, yet does not elicit the allergic reaction |
| 07/22/2004 | US20040141991 novel prostatic acid phosphatase and corresponding coding region derived from mouse; immunizing a subject with a xenogeneic polypeptide antigen, either alone, as part of a viral antigen construct, or as part of a pulsed dendritic cell preparation. |
| 07/22/2004 | US20040141982 Use of genetically engineered antibodies to treat multiple myeloma |
| 07/22/2004 | US20040141981 administering biological conjugates comprising chlorotoxin sensitive cytoplasmic proteins, used for the screening and prophylaxis of cancer |
| 07/22/2004 | US20040141979 isolation and production of cancerous disease modifying antibodies (CDMAB) and to the use of these CDMAB in therapeutic and diagnostic processes; anticancer agents |
| 07/22/2004 | US20040141966 Inhibition of leukocyte adhesion |
| 07/22/2004 | US20040141958 cytotoxic T-cell mediated killing of disease cells that express a weakly immunogenic or non-immunogenic cell-associated polypeptide antigen in an animal by administering a cytotoxic T-cell epitope and a T-helper lymphocyte |
| 07/22/2004 | US20040141918 Nucleotide and deduced amino acid sequences of tumor gene Int6 |
| 07/22/2004 | US20040141917 Antibodies to truncated VEGF-D and uses thereof |
| 07/22/2004 | US20040141915 Cancerous disease modifying antibodies |
| 07/22/2004 | US20040141914 Cancerous disease modifying antibodies |
| 07/22/2004 | US20040141913 Cancerous disease modifying antibodies |
| 07/22/2004 | US20040141912 Administering medicinally-useful agent which is phospholipid scramblase (PLS)-dependent transported compound to cells, thereby causing selective transport of agent into cells |
| 07/22/2004 | DE202004003714U1 New phenyl maleic anhydride and maleimide derivatives used for lowering blood pressure, increasing high-density lipoprotein or as central cholinergic agonists, hepatoprotective, antiinflammatory agents and antitumor agents |
| 07/22/2004 | CA2514477A1 Novel factor viia inhibiting compounds |
| 07/22/2004 | CA2512553A1 Metastin derivatives and their use |
| 07/22/2004 | CA2511817A1 Novel compositions and methods in cancer |
| 07/22/2004 | CA2510050A1 The r-isomer of beta amino acid compounds as integrin receptor antagonists derivatives |
| 07/22/2004 | CA2509758A1 17 beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases |
| 07/22/2004 | CA2509213A1 2-oxopyridin-3-yl thia (di) azole derivates for use in the treatment of cell proliferation and apoptosis related diseases |
| 07/22/2004 | CA2503043A1 Compositions and methods for the diagnosis and treatment of tumor |
| 07/21/2004 | EP1439229A2 Oncogene, recombinant protein derived therefrom, and uses thereof |